Neogen Corporation (NEOG)
NASDAQ: NEOG · Real-Time Price · USD
9.40
-0.21 (-2.19%)
At close: Jul 24, 2026, 4:00 PM EDT
9.41
+0.01 (0.11%)
After-hours: Jul 24, 2026, 7:34 PM EDT
Neogen Financials Overview
Financials in millions USD. Fiscal year is June - May.
Millions USD. Fiscal year is Jun - May.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Feb '26 Feb 28, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 |
Revenue Revenue Growth | 870.54 | 894.66 | 924.22 | 822.45 | 527.16 | 468.46 |
Revenue Growth | -3.91% | -3.20% | 12.38% | 56.02% | 12.53% | 12.03% |
Gross Profit Gross Profit Growth | 393.53 | 421.38 | 463.9 | 405.96 | 243.01 | 215.06 |
Operating Income Operating Income Growth | -3.3 | -1,061 | 58.66 | 37.52 | 58.62 | 74.17 |
Net Income Net Income Growth | -608.83 | -1,092 | -9.42 | -22.87 | 48.31 | 60.88 |
Earnings Per Share EPS Growth | -2.80 | -5.03 | -0.04 | -0.12 | 0.45 | 0.57 |
EPS Growth | - | - | - | - | -21.05% | 1.79% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Feb '26 Feb 28, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 |
Natural Toxins & Allergens Natural Toxins & Allergens Growth | 76.88 | 77.06 | 82.24 | 82.57 | 79.4 | 76.61 |
Bacterial & General Sanitation Bacterial & General Sanitation Growth | 171.12 | 164.78 | 171.22 | 134.93 | 47.28 | 44.01 |
Indicator Testing, Culture Media & Other Indicator Testing, Culture Media & Other Growth | 338.26 | 325.92 | 334.64 | 267.18 | 75.28 | 61.25 |
Biosecurity Products - Food Safety Biosecurity Products - Food Safety Growth | 25.53 | 46.97 | 42.97 | 39.66 | 35.69 | 32.22 |
Genomics Services - Food Safety Genomics Services - Food Safety Growth | 24.34 | 23.42 | 24.28 | 22.46 | 22.33 | 20.16 |
Life Sciences Life Sciences Growth | 6.44 | 6.5 | 6.52 | 6.25 | 5.69 | 5.72 |
Veterinary Instruments & Disposables Veterinary Instruments & Disposables Growth | 57.35 | 61.47 | 65.85 | 63.84 | 63.94 | 48.13 |
Animal Care & Other Animal Care & Other Growth | 30.07 | 34.65 | 36.98 | 39.07 | 39.81 | 35.9 |
Biosecurity Products - Animal Safety Biosecurity Products - Animal Safety Growth | 73.67 | 88.06 | 88.73 | 87.42 | 83.61 | 77.46 |
Genomics Services - Animal Safety Genomics Services - Animal Safety Growth | 66.87 | 65.84 | 70.81 | 79.06 | 74.14 | 67.02 |
Revenue (Total) Revenue (Total) Growth | 870.54 | 894.66 | 924.22 | 822.45 | 527.16 | 468.46 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Feb '26 Feb 28, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 |
Cash & Investments Cash & Investments Growth | 159.9 | 129 | 170.94 | 245.57 | 381.05 | 381.09 |
Total Debt Total Debt Growth | 793.3 | 894.1 | 890.84 | 885.44 | 0 | 0 |
Net Cash (Debt) Net Cash Growth | -633.4 | -765.1 | -719.9 | -639.87 | 381.05 | 381.09 |
Net Cash Growth | - | - | - | - | -0.01% | 10.89% |
Net Cash Per Share Net Cash Per Share Growth | -2.91 | -3.53 | -3.33 | -3.39 | 3.53 | 3.56 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Feb '26 Feb 28, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 69.44 | 58.24 | 35.26 | 41.03 | 68.04 | 81.09 |
Capital Expenditures CapEx Growth | -63.4 | -104.6 | -111.42 | -65.76 | -24.43 | -26.71 |
Free Cash Flow Free Cash Flow Growth | 6.05 | -46.35 | -76.16 | -24.73 | 43.61 | 54.38 |
Free Cash Flow Growth | - | - | - | - | -19.80% | -12.05% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Feb '26 Feb 28, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 |
Gross Margin | 45.21% | 47.10% | 50.19% | 49.36% | 46.10% | 45.91% |
Operating Margin | -0.38% | -118.59% | 6.35% | 4.56% | 11.12% | 15.83% |
Pretax Margin | -72.15% | -126.65% | -1.55% | -2.68% | 11.42% | 16.07% |
Profit Margin | -69.94% | -122.06% | -1.02% | -2.78% | 9.16% | 13.00% |
FCF Margin | 0.69% | -5.18% | -8.24% | -3.01% | 8.27% | 11.61% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 |
PE Ratio | - | - | - | - | 58.80 | 80.96 |
Forward PE | 34.81 | 13.47 | 25.78 | 94.54 | 40.09 | 72.03 |
P/FCF Ratio | 338.26 | - | - | - | 65.41 | 91.21 |
PS Ratio | 2.35 | 1.42 | 3.08 | 4.60 | 5.41 | 10.59 |